Enzymicals announced the appointment of Dr. David Liese as its new Chief Executive Officer, following a long-planned succession programme. Dr. Liese will replace Dr. Erik de Vries, who had already announced his intention to retire from Enzymicals earlier this year.
More information: Press release CEO 011124
